Making a Difference, Here & Beyond
The community invests in Dell Med. In return, it’s our responsibility — one we take seriously — to be agents for change and to show real impact.
OUR WORK
More Information
PARTICIPATE
COLLABORATE
Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
WHAT IT MEANS
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
SEE HOW
More Information
Let’s Do Big Things Together
True health demands that the whole work in harmony, which is why we’re dedicated to partnership. Indeed, we can’t achieve our goals without it.
EXPLORE OPTIONS
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
Make an Appointment Directory Give Faculty Students

Kevin Hackshaw, M.D.

Education

M.D.
Baylor College of Medicine

About

Kevin Hackshaw, M.D., is an associate professor and chief of the Division of Rheumatology in the Department of Internal Medicine.

Hackshaw is pleased to return to the state of Texas and is excited about the opportunities offered at The University of Texas at Austin and Dell Medical School. A native of Brooklyn, New York, he left NYC after graduating from Brooklyn College to attend Baylor College of Medicine. After four years in Houston, he returned to New York and trained in internal medicine at Harlem Hospital Center (Columbia University College of Physicians and Surgeons).

After three years of internal medicine, he served a year as chief resident at Harlem and then relocated for three years as a clinical research fellow in rheumatology at University of Colorado Health Sciences Center. His research focus in Denver was membrane biochemistry, and his initial areas of research interest involved focus on fatty acid metabolism in autoimmune murine models.

After completing his rheumatology fellowship, he accepted a faculty position at The Ohio State University in Columbus, joining the faculty in 1990. His basic research involved fatty acid membrane composition as it relates to promoting inflammation; molecular cloning and characterization of mouse acidic fibroblast growth factors; and evaluation of neurotrophins in experimental pain models with a specific focus on fibroblast growth factors. These studies were conducted over nearly two decades and supported by multiple National Institutes of Health, private foundation and pharmaceutical support.

Following these studies, Hackshaw evolved from utilizing experimental pain models to the human analogues of neuropathic pain, for which fibromyalgia is the prototypical disorder. His current NIH proposal seeks to develop reliable biomarkers that can be utilized to identify and characterize patients with fibromyalgia and hopefully provide a roadmap for identifying targeted therapies for this highly common but poorly understood disorder.

Hackshaw’s specialty interests are fibromyalgia, chronic pain, rheumatoid arthritis, systemic lupus erythematosus and vasculitis. His research interests center around the mechanisms of neurotrophins in propagating chronic pain states.

Time away from work is spent with his wife (Dawn Hackshaw, M.D., a pediatrician) and his children. Leisure pursuits include biking, exercising and avidly following New York Yankee baseball.